Health Condition 1: C23- Malignant neoplasm of gallbladder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients willing to give written informed consent. All patients presented with upper abdominal malignancy either sex having age between 40 and 75 years Patients of upper abdominal malignancy having pain which was not relieved by nonsteroidal anti- inflammatory drug (NSAID) or strong opioids like morphine (according to WHO ladderIII) Patients of upper abdominal malignancy developing complications on low dosages ofmorphine
Exclusion criteria
Exclusion criteria: Patients not willing to participate in the study Patient on anticoagulantiontherapy with deranged coagulation profile local or intra-abdominalinfection, sepsis and hugeascites,patients with bowel obstruction, • with physical opioid dependence and drug seeking behavior.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The intervention outcome depend upon VAS score (0-10) at weekly interval up to 12weeks. either excellent,good,satisfactory or unsatisfactory.Based on 10 cm line, the left extremity represent no pain i.e excellent outcome at all(score0)andrightextremityrepresentunbearable pain(score 10) i.e unsatisfactory outcome, the procedure will be considered successful if there will be satisfactory pain relief VAS score â?¤3 with or without morphine or reduction in the dose of morphine.Timepoint: VAS score (0-10) at weekly interval up to 12weeks i.e at 0 week,1 week,4 week,8 week and 12 week duration. | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the improvement in quality of life between groups. To compare the need of rescue analgesia between groups. To compare the side effect profile between groups.Timepoint: 1-24hrs | — |
Countries
India
Contacts
KING GEORGE MEDICAL UNIVERSITY LUCKNOW